PYC Therapeutics Ltd
F:PH7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PYC Therapeutics Ltd
F:PH7
|
AU |
Intrinsic Value
The intrinsic value of 
PYC Therapeutics Ltd (PH7) under the Base Case is 0.006 EUR per share.
Compared with the current market price of 0.065 EUR, the stock appears
Overvalued by 91% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What PYC Therapeutics Does
PYC Therapeutics is a biotechnology company that develops RNA-based medicines for inherited diseases. Its core idea is to design short RNA molecules that help cells make the right protein when a gene is not working properly. The company is focused on rare disorders with clear genetic causes, where fixing the underlying RNA problem may address the disease itself rather than just the symptoms.
- Headquarters
- Australia AU
- Employees
- 5
- IPO date
- Mar 30, 2005
Earnings Waterfall
PYC Therapeutics Ltd
The intrinsic value for PYC Therapeutics Ltd (PH7) under the Base Case is 0.006 EUR.
Compared with the current market price of 0.065 EUR, the stock appears Overvalued by 91% .